MMP9 and liver cancer: SP-8356 showed anti-atherosclerosis effects by inhibiting the cluster of differentiation 147 (CD147)/matrix metalloproteinase 9 (MMP9) pathway [13,14] and anti-metastatic effects on breast and liver cancers by inhibiting the NF-κB signaling pathway [15,16].